Effects of childhood body size on breast cancer tumour characteristics.
BACKGROUND
Although a role of childhood body size in postmenopausal breast cancer risk has been established, less is known about its influence on tumour characteristics.


METHODS
We studied the relationships between childhood body size and tumour characteristics in a Swedish population-based case-control study consisting of 2,818 breast cancer cases and 3,111 controls. Our classification of childhood body size was derived from a nine-level somatotype. Relative risks were estimated by odds ratios with 95% confidence intervals, derived from fitting unconditional logistic regression models. Association between somatotype at age 7 and tumour characteristics were evaluated in a case-only analysis where P values for heterogeneity were obtained by performing one degree of freedom trend tests.


RESULTS
A large somatotype at age 7 was found to be associated with decreased postmenopausal breast cancer risk. Although strongly associated with other risk factors such as age of menarche, adult body mass index and mammographic density, somatotype at age 7 remained a significant protective factor (odds ratio (OR) comparing large to lean somatotype at age 7 = 0.73, 95% confidence interval (CI) = 0.58-0.91, P trend = 0.004) after adjustment. The significant protective effect was observed within all subgroups defined by estrogen receptor (ER) and progesterone receptor (PR) status, with a stronger effect for ER-negative (0.40, 95% CI = 0.21-0.75, P trend = 0.002), than for ER-positive (0.80, 95% CI = 0.62-1.05, P trend = 0.062), tumours (P heterogeneity = 0.046). Somatotype at age 7 was not associated with tumour size, histology, grade or the presence or absence of metastatic nodes.


CONCLUSIONS
Greater body size at age 7 is associated with a decreased risk of postmenopausal breast cancer, and the associated protective effect is stronger for the ER-negative breast cancer subtype than for the ER-positive subtype.
Li
Jingmei
J
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. jingmei.li@ki.se
Humphreys
Keith
K
Eriksson
Louise
L
Czene
Kamila
K
Liu
Jianjun
J
Hall
Per
P
D000368:Aged; D015992:Body Mass Index; D049628:Body Size / Q000502:physiology*; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology*; D016022:Case-Control Studies; D002648:Child; D005260:Female; D006801:Humans; D016015:Logistic Models; D008207:Lymphatic Metastasis; D008875:Middle Aged; D015999:Multivariate Analysis; D016017:Odds Ratio; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D047368:Tumor Burden
D011960:Receptors, Estrogen; D011980:Receptors, Progesterone
Lancet Oncol. 2005 Oct;6(10):798-808
16198986
Int J Obes (Lond). 2007 Sep;31(9):1392-9
17356523
Cancer. 1999 Jun 1;85(11):2400-9
10357411
Br J Cancer. 2002 Oct 7;87(8):876-82
12373602
Curr Cancer Drug Targets. 2007 Aug;7(5):465-74
17691906
Br J Obstet Gynaecol. 1996 Aug;103(8):814-7
8760713
Am J Epidemiol. 2002 Feb 1;155(3):225-33
11821247
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1680-5
18230721
Int J Cancer. 2008 Mar 1;122(5):1089-94
17960621
Am J Clin Nutr. 2008 Jun;87(6):1769-75
18541567
Hum Reprod. 2008 Apr;23(4):919-27
18227106
Int J Obes Relat Metab Disord. 2003 Jul;27(7):755-77
12821960
Breast Cancer Res Treat. 2008 May;109(1):113-22
17592770
Am J Epidemiol. 2002 Apr 1;155(7):672-9
11914195
Breast Cancer Res. 2008;10(6):R107
19087323
J Clin Endocrinol Metab. 1998 Oct;83(10):3469-75
9768648
Am J Epidemiol. 1993 Jul 1;138(1):56-64
8333427
Br J Cancer. 2001 Nov 30;85(11):1680-4
11742488
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2086-92
17119032
N Engl J Med. 2004 Oct 14;351(16):1619-26
15483280
Eur J Cancer Prev. 2001 Feb;10(1):15-32
11263588
Mol Endocrinol. 2008 Aug;22(8):1812-24
18483177
Maturitas. 2002 Oct 25;43(2):105-12
12385858
Int J Cancer. 1998 Mar 30;76(1):29-34
9533758
Cancer. 1997 Aug 1;80(3):435-41
9241077
Am J Epidemiol. 2009 Jul 1;170(1):72-9
19439580
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):374-8
18250344
Int J Cancer. 2010 Feb 15;126(4):985-91
19642103
Am J Clin Nutr. 2004 Oct;80(4):966-72
15447907
Am J Clin Nutr. 2005 Aug;82(2):456-66
16087993
Carcinogenesis. 2004 May;25(5):741-8
14729590
Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1159-67
14652275
Br J Cancer. 2003 Sep 1;89(5):852-9
12942117
Int J Epidemiol. 2000 Jun;29(3):456-64
10869317
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8
17164374
Ann N Y Acad Sci. 2006 Nov;1089:14-35
17261753